Federal auditors are making unannounced visits to the offices of Oxaro, the company handling Canada's Vaccine Injury Support Program (VISP), to check if they're meeting performance standards. According to a confidential source, these surprise inspections by the Public Health Agency of Canada (PHAC) are part of ongoing oversight—suggesting concerns about how the program is being managed.

Editor’s Note: This isn't just bureaucratic red tape—it signals potential issues with how vaccine injury claims are being processed. Given the sensitive nature of the program (compensating people harmed by vaccines), transparency and efficiency matter. If auditors are showing up unannounced, it hints at deeper problems, which could erode public trust in a system meant to protect them.

Canada's Public Health Agency is taking a closer look at its Vaccine Injury Support Program (VISP) after hearing feedback from participants. They're also checking out how other countries handle similar vaccine injury programs to see what works best.

Oxaro, a consulting firm, has issued a statement saying it's adjusting its approach to VISP (likely a program or initiative, though the details aren't spelled out here). Global News sent them a hefty list of questions—15 pages' worth—but only got partial answers in return. This article stitches together what Oxaro did share, though it’s clear there are gaps in the response.

It's not just one country grappling with vaccine injury claims—Britain's compensation program is under fire too. Critics say the process drags on forever, the bar to qualify is set unrealistically high, and even those who do get payouts often receive disappointingly small amounts.

A new report reveals shocking disorganization within Canada’s Vaccine Injury Support Program (VISP), with former employees describing a lax, unprofessional environment where little actual work got done. One worker even compared it to hanging out at school rather than managing a critical public health initiative.

Newly uncovered documents suggest that VISP, a program touted as independently managed, may not be as autonomous as claimed. The records show that the Public Health Agency of Canada (PHAC) and Oxaro, a private firm, coordinate responses when journalists or lawmakers inquire about the program—raising questions about who’s really calling the shots.

Canada launched a $50 million program to compensate people who experienced severe side effects from COVID-19 vaccines, promising quick and fair payouts. But a Global News investigation found that many claimants say the program is falling short—delays, denials, and bureaucratic hurdles are leaving them frustrated and financially strained. Some feel abandoned after suffering life-altering health issues, despite the government's pledge to support them.